Anaveon

• locale

  Switzerland

• market

  PRIVATE

• industry

  Biotechnology

• website

  anaveon.com

Anaveon transforms cytokines into treatments for cancer immunotherapy. The company is developing ANV419, an IL-2/anti-IL-2 antibody fusion protein with CD8+ T and natural killer cell-stimulating capacity.